Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. Signal., 9 February 2010
[DOI: 10.1126/scisignal.2000590]

Supplementary Materials for:

ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway

Hsu-Ping Kuo, Dung-Fang Lee, Chun-Te Chen, Mo Liu, Chao-Kai Chou, Hong-Jen Lee, Yi Du, Xiaoming Xie, Yongkun Wei, Weiya Xia, Zhang Weihua, Jer-Yen Yang, Chia-Jui Yen, Tzu-Hsuan Huang, Minjia Tan, Gang Xing, Yingming Zhao, Chien-Hsing Lin, Shih-Feng Tsai, Isaiah J. Fidler, Mien-Chie Hung*

*To whom correspondence should be addressed. E-mail: mhung{at}mdanderson.org

This PDF file includes:

  • Fig. S1. Lower copy number of genomic ARD1 was found in ARD1 LOH group.
  • Fig. S2. Endogenous ARD1 in five cell lines with low ARD1 abundance and five cell lines with high ARD1 abundance.
  • Fig. S3. Myc-ARD1 had a stronger growth-inhibitory effect in tumor cells with lower endogenous ARD1 than in cells with abundant endogenous ARD1.
  • Fig. S4. Knockdown of ARD1 with either of two different siRNAs increased the growth of MDA-MB-435 cells.
  • Fig. S5. ARD1 reduced the degree of pS6K1(T389) whereas depletion of ARD1 increased pS6K1(T389) under conditions of both serum starvation and insulin-like growth factor (IGF) stimulation.
  • Fig. S6. ARD1 reduced p4EBP1(S65) under conditions of both serum starvation and IGF stimulation.
  • Fig. S7. Transient transfection of Myc-ARD1 increased the amount of TSC2 in HEK293T cells.
  • Fig. S8. Depletion of ARD1 decreased the stability of TSC2.
  • Fig. S9. The data of Fig. 6B on a semilog plot.
  • Fig. S10. Treatment of MG132 increased TSC2 abundance.
  • Fig. S11. Schematic shows wild-type (WT) ARD1 and three truncated forms of ARD1.
  • Fig. S12. WT ARD1, but not ARD1 ΔC, increased the stability of TSC2.
  • Fig. S13. WT ARD1, but not ARD1 AA or ARD1 ΔAT, stabilized TSC2.
  • Fig. S14. WT ARD1, but not ARD1 AA or ARD1 ΔAT, reduced ubiquitination of TSC2.
  • Fig. S15. WT ARD1, but not ARD1 AA or ARD1 ΔAT, significantly suppressed the growth of MDA-MB-435 and MCF-7 cells.
  • Fig. S16. Depletion of ARD1 decreased the acetylation of endogenous TSC2.
  • Fig. S17. We detected no ARD1-induced ε-acetylation of TSC2.
  • Fig. S18. Shown are two representative breast cancer specimens with consecutive sections.
  • Fig. S19. Representative images of ARD1 and TSC2 abundance in four different types of cancers.
  • Table S1. Relationship between ARD1 and TSC2 in surgical specimens of various tumors.

[Download PDF]

Technical Details

Format: Adobe Acrobat PDF

Size: 697 KB


Citation: H.-P. Kuo, D.-F. Lee, C.-T. Chen, M. Liu, C.-K. Chou, H.-J.Lee, Y. Du, X. Xie, Y. Wei, W. Xia, Z. Weihua, J.-Y. Yang, C.-J. Yen, T.-H. Huang, M. Tan, G. Xing, Y. Zhao, C.-H. Lin, S.-F. Tsai, I. J. Fidler, M.-C. Hung, ARD1 Stabilization of TSC2 Suppresses Tumorigenesis Through the mTOR Signaling Pathway. Sci. Signal. 3, ra9 (2010).

© 2010 American Association for the Advancement of Science


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882